A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression

NCT06285916 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression, Postpartum
Postpartum Depression
Post-partum Depression
Postnatal Depression
Post-Natal Depression

Interventions

DRUG: NORA520 Dose 1
DRUG: NORA520 Dose 2
DRUG: Placebo

Sponsor

DuKang Pharmaceuticals, Inc.